FLT-PET/DW-MRI for Detection of Brain Metastases and Early Therapy Evaluation in Patients With Small Cell Lung Cancer

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02995902

Acronym

SIBES II

Enrollment

Registered

2016-12-19

Start date

2014-12-11

Completion date

2018-02-08

Last updated

2022-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Small Cell Lung Cancer

Brief summary

The purpose of the study is to determine the value of FLT-PET early after initiated chemotherapy in patients with small cell lung cancer, and to determine whether MRI of the brain should be performed routinely in these patients.

Interventions

DEVICEFLT-PET

DEVICEMRI

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* biopsy proven small cell lung cancer * referred for standard chemotherapy * oral and written informed consent

Exclusion criteria

* metal or electronical devices in the body not compatible with MRI of brain or thorax * pregnancy or lactation * communication difficulties

Design outcomes

Primary

Measure	Time frame
Overall survival	1 year
Disease free survival	1 year

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026